Ageing
Crepey Skin
Excessive sweating
Pigmentation
Eye smile lines
Sagging Jaw Line
Acne
Rosacea
Hair Loss
Weight Gain
Thin Lips
Home
Shop
Blog
About
Treatments
Get in Touch
Concerns
Book
Under eye shadows
Male Hair Loss
Ageing Hands
Stretch Marks
Cellulite
Neck Lines
Nose to mouth lines
Mouth to chin lines
Facial Asymmetry
Frown Lines
Menopausal Skin
Home
About
Treatments
Blog
Sculptra in Burford, Oxfordshire
Written and clinically reviewed by
Vaiva Mikalauskaite,
MPharm, PGDip Clinical Pharmacy, Independent Prescriber,
Face for Soul, Burford, Oxfordshire.
Last reviewed July 2026.
- Sculptra is a collagen biostimulator made of poly-L-lactic acid microparticles. It does not fill; it prompts your own fibroblasts to produce new collagen over months.
- It was not designed as a cosmetic product. Poly-L-lactic acid had decades of medical use in dissolvable sutures and implants, and Sculptra was approved by the FDA in August 2004 to treat facial lipoatrophy in people living with HIV. Aesthetic approval followed in July 2009.
- Results build gradually. A 2024 systematic review of eleven randomised controlled trials reported increased dermal thickness and improvement sustained for at least 25 months in several trials.
- Sculptra cannot be dissolved. Unlike hyaluronic acid fillers, there is no reversal agent, which is why conservative planning matters more here than with almost any other injectable.
- The main risk is delayed nodules, and it is strongly linked to how the product is prepared and placed rather than to the product itself.
- Higher reconstitution volumes reduce nodule risk. The originally approved volume was 3 to 4 mL. It rose to 5 mL with aesthetic approval, and current practice commonly uses 8 to 9 mL for the face and up to 16 mL off face.
- Sculptra is used on the face and, for selected patients, on the neck, décolletage, hands and body.
What is Sculptra?
Sculptra is an injectable collagen biostimulator containing microparticles of poly-L-lactic acid, supplied as a freeze-dried powder in a 150 mg vial that must be reconstituted before use. Rather than filling a hollow directly, the microparticles prompt a controlled response in the skin that activates fibroblasts, the cells responsible for producing collagen.
Over the following weeks and months the treated areas gradually rebuild structural support with your own collagen. The product itself is broken down and cleared by the body. What remains is the tissue your skin has produced, which is why Sculptra results look like you rather than like something added to your face.
Sculptra at a glance
Why preparation is the treatment
With Sculptra, what happens to the vial before it reaches your face determines the result more than almost any other factor. This is the part of the treatment patients never see and few clinics explain.
Sculptra arrives as a powder. It must be reconstituted with sterile water, left to hydrate, and injected into the correct plane, and every one of those decisions changes the outcome. The history proves it. The original 2004 approval for HIV-associated facial lipoatrophy used just 3 to 4 mL of sterile water with a two-hour hydration time, and that era produced the nodule reputation Sculptra still carries. When the aesthetic approval followed in 2009, the recommended volume had risen to 5 mL, because higher dilutions had been shown to markedly decrease the incidence of visible papules and nodules. An inverse relationship between dilution volume and nodule incidence has been reported in both facial and non-facial use.
Practice has continued to evolve. Reconstitution volumes commonly used now are 8 to 9 mL for facial treatment and up to 16 mL for off-face areas, with hydration typically over 24 to 72 hours, and the manufacturer’s instructions state that reconstituted product must be injected within 72 hours.
A landmark technical paper set out the principles that still define safe practice: higher volume dilution, fewer vials used per session, injection into the subcutaneous plane with no product placed in the dermis, at least six weeks between sessions, and post-injection massage.
Lam SM, Azizzadeh B, Graivier M. Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring. Plast Reconstr Surg. 2006. PubMed PMID: 16936545. View on PubMed →
The conclusion is uncomfortable for the industry and useful for patients: most Sculptra complications are not product failures. They are preparation and placement failures. This is why the same vial produces beautiful results in one clinic and problems in another, and it is why technique is worth asking about before you book.
DECISION
WHY IT
MATTERS
Reconstitution volume
Higher dilution is associated with lower nodule incidence. The approved volume rose from 3 to 4 mL in 2004 to 5 mL in 2009, and common practice now exceeds both.
Hydration time
Allows even particle distribution before injection. Uneven suspension concentrates product where it is not wanted.
Injection plane
Subcutaneous or supraperiosteal, never the dermis. Superficial placement is a principal cause of visible papules.
Volume per session
Fewer vials per session, with treatment built gradually rather than delivered all at once.
Interval between sessions
At least six weeks, so the collagen response can be assessed before more is added.
Massage protocol
Distributes product evenly in the days after treatment, and is part of minimising nodule risk.
Sculptra’s history explains its character. Poly-L-lactic acid was not invented for faces; it had been used in medicine for decades in dissolvable surgical sutures, bone implants and drug delivery systems, precisely because the body breaks it down safely.
Its move into the face came from clinical need. Introduced in Europe as New-Fill in 1999, it became one of the few genuine options for people living with HIV who had developed facial lipoatrophy: severe, visible loss of the fat pads of the cheeks and temples. Published research documented how profoundly that affected quality of life, stigma and even willingness to continue treatment. In August 2004 the FDA approved Sculptra for that indication. Aesthetic approval for healthy patients followed only in July 2009.
Two things follow. First, this is a product built to rebuild faces that had genuinely lost structure, which is why it behaves so well for real volume loss and so poorly as a way of adding volume to a face that never lost any. Second, the difficult early years taught the technique lessons described above, and those lessons are the reason modern Sculptra is a far safer treatment than its reputation suggests.
From HIV clinics to regenerative aesthetics: where Sculptra came from
From our thirties onwards, collagen production declines and the deep support structures of the face gradually thin. The result is rarely a single line. It is a general change: cheeks that look less supported, temples and mid-face subtly deflated, skin that has lost firmness, and a face that reads as tired when you are not.
Sculptra can be considered, for the right patient, for gradual improvement of facial volume loss, softening of deeper folds driven by lost support, improvement in skin firmness and quality over time, and, in selected patients, for crepey, poorly supported skin of the neck, décolletage, hands and body.
It often suits patients who dislike the idea of looking done, who want change that arrives slowly and reads as natural, and who are thinking in terms of the next few years rather than the next fortnight.
Why do patients consider Sculptra?
For the right patient, once weight is stable, yes. Rapid weight loss, with or without GLP-1 medication, shrinks the fat pads of the temples and mid-face faster than the skin above them can adapt, producing diffuse hollowing and a gaunt look alongside genuinely improved health.
Vaiva contributed featured expert commentary on Glowday on exactly this subject, and her published position shapes how it is treated here: facial fat is biologically active tissue, not passive volume, so the honest plan supports nutrition, skin quality and collagen first, then restores structure carefully where genuinely needed. Sculptra suits the diffuse pattern of weight-loss hollowing particularly well, because it rebuilds gradually across the areas that have thinned rather than placing volume in single points.
One rule is not negotiable: structural biostimulation waits until weight has been stable for around three to six months. Treating a face that is still changing means building on a moving target. If you are still losing weight you are at the skin-quality stage of the plan, not too early for help.
Can Sculptra treat Ozempic face?
What does the research say?
A 2024 systematic review published in Polymers examined eleven randomised controlled trials of poly-L-lactic acid for facial ageing and volume loss. The included studies reported increased dermal thickness and significant improvement in clinical severity and aesthetic scores, with effects sustained for at least 25 months in several trials, and two studies demonstrating superiority over injectable collagen.
Efficacy and Safety of Poly-l-Lactic Acid in Facial Aesthetics: A Systematic Review. Polymers. 2024;16(18):2564.
Read the review →
A published multicentre post-market study of a poly-L-lactic acid collagen stimulator followed treatment across five body areas: the neck, upper arms, hands, thighs and décolletage, with high reported satisfaction across nine months of follow-up.
Safety and effectiveness results of an injectable poly-L-lactic acid-based collagen stimulator: clinical outcomes at 9 months in a post-market study. PMC11626332.
View the study →
They are different instruments for different jobs, and the honest comparison is between your anatomy and your goals rather than between brands.
Sculptra, Radiesse, Lanluma or Juvelook: which is right?
Sculptra and Lanluma are both poly-L-lactic acid and work by the same biological mechanism. The practical differences are vial size and formulation focus, with Lanluma X supplied in a larger vial designed for large body areas. For facial work, product choice matters far less than the assessment, preparation and technique behind it.
Product
Material
Sculptra
Poly-L-lactic acid, 150 mg per vial
Radiesse
Calcium hydroxy-lapatite
Lanluma
Poly-L-lactic acid, 210 mg per vial (V) and 630 mg per vial (X)
Juvelook
PDLLA with non-crosslinked hyaluronic acid
What it
does
Usually
suits
Gradual collagen stimu-lation, no imme-diate volume
Diffuse thinning across the face, patients happy for change over months
Immediate structural support
plus
collagen stimu-lation
Jawline definition and defined structural goals; also used hyper-diluted for skin quality
Gradual collagen stimulation, with larger vials formulated for body areas
Patients wanting PLLA for larger body areas such as buttocks and thighs
Fine-particle collagen stimulation with hydration
Skin quality, fine lines and delicate areas including under the eyes
Collagen loss does not stop at the jawline. Because Sculptra works by prompting your own tissue to rebuild rather than by adding bulk, it suits areas where the problem is thin, crepey, poorly supported skin rather than absent volume.
The areas patients most often ask about are the neck, where skin thins and crepes early; the décolletage, where decades of sun exposure show first; the hands, where volume loss exposes tendons and veins; and areas of body laxity such as the upper arms and knees. Off-face treatment uses higher reconstitution volumes than facial treatment, results build over months exactly as they do on the face, and technique matters more rather than less because the skin is thinner and less forgiving.
Beyond the face: neck, décolletage, hands and body
Treatment may be delayed, adapted or declined for patients who are pregnant or breastfeeding, are still actively losing significant weight, have active skin infection or inflammation, have a history of keloid or hypertrophic scarring, or have certain autoimmune or healing conditions. The manufacturer’s guidance also advises caution in patients on immunosuppressive therapy, and states plainly that patients with unattainable expectations are not suitable candidates.
Where the concern is skin quality rather than lost structure, Juvelook, polynucleotides, Morpheus8 or skincare may serve you considerably better. If Sculptra is not right for you, you will be told so, and told why.
Who may need a different plan?
Sculptra is delivered as a course, most commonly two to three sessions spaced at least six weeks apart, depending on age, the degree of volume change and the response to earlier sessions. New injectable patients always begin with a consultation, and treatment never takes place on the day of a first injectable consultation.
On the day, the prepared product is injected into the planned areas in the correct plane, with comfort measures discussed beforehand. Afterwards you are given a specific aftercare plan including a structured daily massage routine, explained and demonstrated at your appointment. The massage is not optional politeness. It helps distribute the product evenly while the collagen response begins, and it is part of minimising nodule risk.
What does treatment involve?
Immediately after treatment there is temporary fullness from the water used to prepare the product. This settles within days and it is not your result. The genuine change builds gradually as collagen production develops over the following weeks and months, typically becoming meaningful after the course is complete and continuing to improve afterwards.
Published studies have reported effects sustained for two years or more. Individual duration varies according to age, skin quality, lifestyle and the treatment plan delivered, and a realistic personal expectation is given at consultation rather than a universal promise.
What results should you expect, and when?
What are the risks?
Common short-term effects include swelling, redness, tenderness and bruising at injection sites, settling over days. The most discussed longer-term risk is delayed subcutaneous nodules or papules, which the manufacturer notes may occur between one and fourteen months after injection and can persist, sometimes resolving spontaneously.
Nodule risk is strongly linked to reconstitution volume, hydration, injection plane, volume per session and aftercare massage, which is why the preparation section above exists and why practitioner technique matters more with biostimulators than with almost any other injectable. As with any injectable, rare vascular complications are possible.
Because Sculptra builds your own tissue, it also cannot be dissolved the way hyaluronic acid fillers can. Conservative, gradual planning is not caution for its own sake. It is the correct clinical response to a treatment whose results are long-lived.
Klardie Fusicare Intensive Barrier Ampoule | £75
An intensive calming ampoule particularly valuable in the first days after Morpheus8, when the skin barrier is healing and needs concentrated, gentle support.
100 percent mineral SPF. Non-irritating, rosacea-safe daily sun protection. SPF is non-negotiable for rosacea management.
Sente Dermal Repair Cream | From £125
100 percent mineral SPF. Daily sun protection is essential after radiofrequency microneedling to protect healing skin and guard against pigmentation change while remodelling continues.
Obagi Sun Shield Mineral Broad Spectrum SPF 50 | £75
Revision Skincare Intellishade TruPhysical SPF 45 | £65
Tinted mineral SPF offering daily protection with light coverage, a practical option once your skin is ready for a tinted product after treatment.
Obagi Rebalance Skin Barrier Recovery Cream | £100
Lightweight barrier recovery cream with BarrierPlex Technology. A good option for patients who want post-treatment hydration without heaviness.
100 percent mineral SPF. Daily sun protection is essential after radiofrequency microneedling to protect healing skin and guard against pigmentation change while remodelling continues.
Obagi Sun Shield Mineral Broad Spectrum SPF 50 | £75
Shop Post Treatment Skincare
Face for Soul is based at Castles Yard in Burford, Oxfordshire, in the heart of the Cotswolds. Patients travel for Sculptra consultations from Witney, Carterton, Chipping Norton, Oxford, Cheltenham and across the wider Cotswolds and Oxfordshire, often specifically because they want a conservative, prescriber-led approach to a treatment whose results are long-lived and whose preparation deserves care.
The clinic also sees patients in Chipping Norton. Please mention when booking if you would prefer to be seen there.
Sculptra consultations in Burford and across the Cotswolds
Let's chat
Book your Sculptra consultation
If you are considering Sculptra in Burford, Oxfordshire or anywhere in the Cotswolds, the right first step is an honest assessment of your facial anatomy and whether gradual collagen biostimulation is the right treatment for you. New injectable patients always begin with a consultation.
To book, use the booking link or email info@faceforsoul.co.uk.
